Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract

Leukemia and Lymphoma

Volumn 47, Issue 7, 2006, Pages 1265-1273

  Kim, Seok Jin ^a   Kim, Byung Soo ^a   Choi, Chul Won ^a   Seo, Hee Yun ^a   Seol, Hye Ryoung ^a   Sung, Hwa Jung ^a   Kim, In Sun ^a   Kim, Chul Yong ^a   Jung, Kwang Yoon ^a   Kim, Jun Suk ^a  

^a Korea University Ansan Hospital   (South Korea)

Author keywords

Chemotherapy; Extranodal lymphoma; NK T cell; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; BETA 2 MICROGLOBULIN; BLEOMYCIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; LACTATE DEHYDROGENASE; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER LOCALIZATION; CANCER REGRESSION; CANCER RELAPSE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DISEASE FREE SURVIVAL; DRUG DOSE REGIMEN; DRUG FATALITY; DRUG RESPONSE; DRUG TREATMENT FAILURE; FEMALE; HUMAN; MALE; NASOPHARYNX CANCER; NATURAL KILLER CELL; NOSE CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; T CELL LYMPHOMA; TREATMENT OUTCOME; UPPER GASTROINTESTINAL TRACT;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; EPIRUBICIN; FEMALE; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; PREDNISONE; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REMISSION INDUCTION; TIME FACTORS; TREATMENT OUTCOME; VINCRISTINE;

EID: 33747698361     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600565651     Document Type: Article

References (27)

1. Harris, N and Jaffe, E and Diebold, J and Flandrin, G and Muller-Hermelink, H and Vardiman, J and (1999). World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting. Airlie House Virginia November 1997. In [pp. 3835-3849].
2. Jaffe, E and Chan, J and Su, I and Frizzera, G and Mori, S and Feller, A and (1996) Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol, 20, pp. 103-111.
3. Cheung, M and Chan, J and Wong, K. (2003) Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias Semin Hematol, 40, pp. 221-232.
4. Ribrag, V and Ell Hajj, M and Janot, F and Girinsky, T and Domenge, C and Schwaab, G and (2001) Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx Leukemia, 15, pp. 1123-1126.
5. Chen, H and Fong, L and Su, I and Ting, L and Hong, R and Leung, H and (1996) Experience of radiotherapy in lethal midline granuloma with special emphasis on centrofacial T-cell lymphoma: A retrospective analysis covering a 34-year period Radiother Oncol, 38, pp. 1-6.
6. Sobrevilla-Calvo, P and Meneses, A and Alfaro, P and Bares, J and Amador, J and Reynoso, E and (1993) Radiotherapy compared to chemotherapy as initial treatment of angiocentric centrofacial lymphoma (polymorphic reticulosis) Acta Oncol, 32, pp. 69-72.
7. Aviles, A and Diaz, N and Neri, N and Cleto, S and Talawera, A. (2000) Angiocentric nasal T/natural killer cell lymphoma: A single centre study of prognostic factors in 108 patients Clin Lab Haematol, 22, pp. 215-220.
8. Logsdon, M and Ha, C and Kavadi, V and Cabanillas, F and Hess, M and Cox, J and (1997) Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy Cancer, 80, pp. 477-488.
9. Kim, G and Cho, J and Yang, W and Chung, E and Suh, C and Park, K and (2000) Angiocentric lymphoma of the head and neck: Patterns of systemic failure after radiation treatment J Clin Oncol, 18, pp. 54-63.
10. Kim, W and Song, S and Ahn, Y and Ko, Y and Baek, C and Kim, D and (2001) CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma Ann Oncol, 12, pp. 349-352.
11. Li, Y and Coucke, P and Li, J and Gu, D and Liu, X and Zhou, L and (1998) Primary non-Hodgkin's lymphoma of the nasal cavity: Prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy Cancer, 83, pp. 449-456.
12. Kwong, Y and Chan, A and Liang, R and Chiang, A and Chim, C and Chan, T and (1997) CD56+ NK lymphomas: Clinicopathological features and prognosis Br J Haematol, 97, pp. 821-829.
13. Shikama, N and Izuno, I and Oguchi, M and Gomi, K and Sone, S and Takei, K and (1997) Clinical stage IE primary lymphoma of the nasal cavity: radiation therapy and chemotherapy Radiology, 204, pp. 467-470.
14. Hirakawa, S and Kuyama, M and Takahashi, S and Yamasaki, O and Kanzaki, H and Teshima, T and (1999) Nasal and nasal-type natural killer/T-cell lymphoma J Am Acad Dermatol, 40, pp. 268-272.
15. You, J and Chi, K and Yang, M and Chen, C and Ho, C and Chau, W and (2004) Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: A single institute survey in Taiwan Ann Oncol, 15, pp. 618-625.
16. Cheung, M and Chan, J and Lau, W and Ngan, R and Foo, W. (2002) Early stage nasal NK/T-cell lymphoma: Clinical outcome, prognostic factors, and the effect of treatment modality Int J Radiat Oncol Biol Phys, 54, pp. 182-190.
17. Kim, T and Park, Y and Lee, S and Kim, J and Kim, D and Im, S and (2005) Local tumor invasiveness is more predictive of survival than international prognostic index in stage IE/IIE extranodal NK/T-cell lymphoma, nasal type Blood, 106, pp. 3785-3790.
18. Jaffe, E and Krenacs, L and Kumar, S and Kingma, D and Raffeld, M. (1999) Extranodal peripheral T-cell and NK-cell neoplasms Am J Clin Pathol, 111, pp. S46-55.
19. Lee, J and Park, Y and Kim, W and Lee, S and Ryoo, B and Yang, S and (2005) Extranodal nasal type NK/T-cell Lymphoma: Elucidating clinical prognostic factors for risk-based stratification of therapy Eur J Cancer, 41, pp. 1402-1408.
20. Lee, J and Kim, W and Park, Y and Park, S and Park, K and Kang, J and (2005) Nasal-type NK/T cell lymphoma: Clinical features and treatment outcome Br J Cancer, 92, pp. 1226-1230.
21. Cheson, B and Horning, S and Coiffier, B and Shipp, M and Fisher, R and Connors, J and (1999) Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group J Clin Oncol, 17, pp. 1244.
22. Chim, C and Ma, S and Au, W and Choy, C and Lie, A and Liang, R and (2004) Primary nasal natural killer cell lymphoma: Long-term treatment outcome and relationship with the International Prognostic Index Blood, 103, pp. 216-221.
23. Kim, G and Lee, S and Chang, S and Park, H and Pyo, H and Kim, J and (2001) Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck Radiother Oncol, 61, pp. 261-269.
24. Kim, B and Kim, T and Kim, C and Kim, J and Heo, D and Bang, Y and (2003) Therapeutic outcome of extranodal NK/T-cell lymphoma initially treated with chemotherapy - result of chemotherapy in NK/T-cell lymphoma Acta Oncol, 42, pp. 779-783.
25. Kim, K and Chie, E and Kim, C and Kim, I and Park, C. (2005) Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: radiotherapy versus chemoradiotherapy Jpn J Clin Oncol, 35, pp. 1-5.
26. Drenou, B and Lamy, T and Amiot, L and Fardel, O and Caulet-Maugendre, S and Sasportes, M and (1997) CD3 - CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance Blood, 89, pp. 2966-2974.
27. Yamaguchi, M and Kita, K and Miwa, H and Nishii, K and Oka, K and Ohno, T and (1995) Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells Cancer, 76, pp. 2351-2356.